Viewing Study NCT01682902


Ignite Creation Date: 2025-12-25 @ 3:46 AM
Ignite Modification Date: 2026-06-06 @ 6:04 PM
Study NCT ID: NCT01682902
Status: COMPLETED
Last Update Posted: 2017-01-09
First Post: 2012-08-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLogĀ® in Subjects With Type 1 Diabetes
Sponsor: Novo Nordisk A/S
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes View
None Diabetes Mellitus, Type 1 View
Keywords: